Alan S. Braverman

1.8k total citations
74 papers, 1.3k citations indexed

About

Alan S. Braverman is a scholar working on Urology, Surgery and Molecular Biology. According to data from OpenAlex, Alan S. Braverman has authored 74 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Urology, 19 papers in Surgery and 19 papers in Molecular Biology. Recurrent topics in Alan S. Braverman's work include Urinary Bladder and Prostate Research (35 papers), Receptor Mechanisms and Signaling (14 papers) and Neuropeptides and Animal Physiology (13 papers). Alan S. Braverman is often cited by papers focused on Urinary Bladder and Prostate Research (35 papers), Receptor Mechanisms and Signaling (14 papers) and Neuropeptides and Animal Physiology (13 papers). Alan S. Braverman collaborates with scholars based in United States, Netherlands and United Kingdom. Alan S. Braverman's co-authors include Michael R. Ruggieri, G R Luthin, Michel A. Pontari, Mary F. Barbe, Martin C. Michel, Elfaridah P. Frazier, Stephan L.M. Peters, Anil K. Vegesna, Justin M. Brown and Larry S. Miller and has published in prestigious journals such as Gastroenterology, PLoS ONE and The FASEB Journal.

In The Last Decade

Alan S. Braverman

73 papers receiving 1.3k citations

Peers

Alan S. Braverman
Youko Ikeda United States
A.J. Haven United Kingdom
E Pedersen Denmark
Shin Suda Japan
Gunjan Joshi United States
Alan S. Braverman
Citations per year, relative to Alan S. Braverman Alan S. Braverman (= 1×) peers Katsumi Sasaki

Countries citing papers authored by Alan S. Braverman

Since Specialization
Citations

This map shows the geographic impact of Alan S. Braverman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan S. Braverman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan S. Braverman more than expected).

Fields of papers citing papers by Alan S. Braverman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan S. Braverman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan S. Braverman. The network helps show where Alan S. Braverman may publish in the future.

Co-authorship network of co-authors of Alan S. Braverman

This figure shows the co-authorship network connecting the top 25 collaborators of Alan S. Braverman. A scholar is included among the top collaborators of Alan S. Braverman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan S. Braverman. Alan S. Braverman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barbe, Mary F., et al.. (2022). Lateralization of bladder function in normal female canines. PLoS ONE. 17(3). e0264382–e0264382.
2.
Barbe, Mary F., et al.. (2019). Fully implantable neural recording and stimulation interfaces: Peripheral nerve interface applications. Journal of Neuroscience Methods. 333. 108562–108562. 31 indexed citations
4.
Barbe, Mary F., et al.. (2016). Bladder reinnervation by nerve transfer using a primarily motor donor nerve (femoral nerve branches) induces increased sympathetic bladder innervation. Neurourology and Urodynamics. 1 indexed citations
5.
Braverman, Alan S., et al.. (2014). Alterations in Nerve-Evoked Bladder Contractions in a Coronavirus-Induced Mouse Model of Multiple Sclerosis. PLoS ONE. 9(10). e109314–e109314. 6 indexed citations
6.
Merali, Salim, Carlos A. Barrero, Russell P. Bowler, et al.. (2013). Analysis of the Plasma Proteome in COPD: Novel Low Abundance Proteins Reflect the Severity of Lung Remodeling. COPD Journal of Chronic Obstructive Pulmonary Disease. 11(2). 177–189. 36 indexed citations
7.
Vegesna, Anil K., Joshua A. Sloan, Balbir Singh, et al.. (2012). Characterization of the distal esophagus high‐pressure zone with manometry, ultrasound and micro‐computed tomography. Neurogastroenterology & Motility. 25(1). 53–53. 13 indexed citations
8.
Miller, Larry S., Anil K. Vegesna, James G. Brasseur, Alan S. Braverman, & Michael R. Ruggieri. (2011). The esophagogastric junction. Annals of the New York Academy of Sciences. 1232(1). 323–330. 14 indexed citations
9.
Barbe, Mary F., Justin M. Brown, Michel A. Pontari, et al.. (2011). Feasibility of a femoral nerve motor branch for transfer to the pudendal nerve for restoring continence: a cadaveric study. Journal of Neurosurgery Spine. 15(5). 526–531. 16 indexed citations
10.
11.
Frazier, Elfaridah P., Alan S. Braverman, Stephan L.M. Peters, Martin C. Michel, & Michael R. Ruggieri. (2007). Does Phospholipase C Mediate Muscarinic Receptor-Induced Rat Urinary Bladder Contraction?. Journal of Pharmacology and Experimental Therapeutics. 322(3). 998–1002. 26 indexed citations
12.
Frazier, Elfaridah P., Stephan L.M. Peters, Alan S. Braverman, Michael R. Ruggieri, & Martin C. Michel. (2007). Signal transduction underlying the control of urinary bladder smooth muscle tone by muscarinic receptors and β-adrenoceptors. Naunyn-Schmiedeberg s Archives of Pharmacology. 377(4-6). 449–462. 125 indexed citations
13.
Braverman, Alan S., Leo Doumanian, & Michael R. Ruggieri. (2006). M2 and M3 Muscarinic Receptor Activation of Urinary Bladder Contractile Signal Transduction. II. Denervated Rat Bladder. Journal of Pharmacology and Experimental Therapeutics. 316(2). 875–880. 36 indexed citations
14.
Ruggieri, Michael R. & Alan S. Braverman. (2006). Regulation of bladder muscarinic receptor subtypes by experimental pathologies. Autonomic and Autacoid Pharmacology. 26(3). 311–325. 37 indexed citations
15.
Braverman, Alan S., et al.. (2006). M2mediated contractions of human bladder from organ donors is associated with an increase in urothelial muscarinic receptors. Neurourology and Urodynamics. 26(1). 63–70. 26 indexed citations
16.
Braverman, Alan S., et al.. (2006). M2 and M3 Muscarinic Receptor Activation of Urinary Bladder Contractile Signal Transduction. I. Normal Rat Bladder. Journal of Pharmacology and Experimental Therapeutics. 316(2). 869–874. 58 indexed citations
17.
Braverman, Alan S. & Michael R. Ruggieri. (2005). Muscarinic receptor transcript and protein density in hypertrophied and atrophied rat urinary bladder. Neurourology and Urodynamics. 25(1). 55–61. 12 indexed citations
18.
Braverman, Alan S. & Michael R. Ruggieri. (2003). Hypertrophy changes the muscarinic receptor subtype mediating bladder contraction from M3toward M2. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 285(3). R701–R708. 77 indexed citations
19.
Braverman, Alan S. & Michael R. Ruggieri. (1999). Selective Alkylation of Rat Urinary Bladder Muscarinic Receptors with 4-DAMP Mustard Reveals a Contractile Function for the M2Muscarinic Receptor. Journal of Receptors and Signal Transduction. 19(5). 819–833. 20 indexed citations
20.
Young, Michael D., et al.. (1989). Determining the optimal dosage regimen for H2‐receptor antagonist therapy—a dose validation approach. Alimentary Pharmacology & Therapeutics. 3(1). 47–57. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026